Eric Devroe
About Eric Devroe
Eric Devroe's Current Role as Chief Operating Officer
Eric Devroe serves as the Chief Operating Officer. His role involves overseeing the day-to-day operations and ensuring that the company's strategic goals are met. With extensive experience in leadership positions, he provides guidance to the executive team and drives operational efficiencies within the organization.
Founder and CEO of Xione Therapeutics and Opsonix
Eric Devroe is the founder and CEO of both Xione Therapeutics and Opsonix. These companies are focused on developing innovative therapeutic solutions. As the CEO, Devroe is responsible for steering the vision, strategy, and growth of these organizations, leveraging his extensive experience in the biotech and healthcare sectors.
Past Role at MD Anderson Cancer Center
Eric Devroe previously held the position of Executive Director of Strategic Alliances at MD Anderson Cancer Center. In this role, he was responsible for forming and managing strategic collaborations that aligned with the center's mission to end cancer. His efforts contributed to fostering partnerships that enhanced research and development in oncology.
Industry Background at Metamark Genetics and Wyss Institute
Eric Devroe also served as the Vice President of Business Development at Metamark Genetics, where he led initiatives to drive the company's growth through strategic business opportunities. Additionally, he was an Entrepreneur in Residence at the Wyss Institute at Harvard, where he supported early-stage biotech ventures, bringing innovative technologies to market.
Educational Background in Microbiology and Biological Chemistry
Eric Devroe holds a B.S. in Microbiology from the University of Texas at Austin and a Ph.D. in Biological Chemistry and Molecular Pharmacology from Harvard University. His educational background has equipped him with a deep understanding of the scientific principles underpinning his work in biotechnology and therapeutic development.